Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 2,133 Jan 1 – Oct 9, 2026
- Disclosed funding
- $200.1B 1766 disclosed amounts
- Median round
- $24M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| B BiotaCompany profile Environmental diagnostics company developing faster technologies for PFAS monitoring and analysis. Environmental diagnostics company developing faster technologies for PFAS monitoring and analysis. | $3M | Seed | Climate tech | United States | Investors | |
| C Relationship intelligence platform for enterprise revenue teams | $19M | Seed+Seed | Enterprise software | United States | Investors | |
| HA Henry AICompany profile AI platform automating back-office knowledge work for commercial real estate teams AI platform automating back-office knowledge work for commercial real estate teams | $16.5M | Series A | Proptech | United States | Investors | |
| AT Adjuvia TherapeuticsCompany profile Adjuvia develops oral nanoparticle therapies intended to address mitochondrial dysfunction, starting with its ATI-105 program for rare diseases. Adjuvia develops oral nanoparticle therapies intended to address mitochondrial dysfunction, starting with its ATI-105 program for rare diseases. | $8M | Seed | Biotech | United States | Investors | |
| A ArchCompany profile Arch helps investors, advisers and family offices administer private-market portfolios by collecting documents, standardizing data and coordinating investment workflows. Arch helps investors, advisers and family offices administer private-market portfolios by collecting documents, standardizing data and coordinating investment workflows. | $52M | Series B | Fintech | United States | Investors | |
| C ChipAgentsCompany profile ChipAgents develops AI tools that turn chip specifications and code into RTL, verification assets and root-cause analysis. ChipAgents develops AI tools that turn chip specifications and code into RTL, verification assets and root-cause analysis. | $60M | Series A+Series A | Hardware | United States | Investors | |
| PB Physician-led behavioral health services and technology company | $14.2M | Growth | Healthtech | United States | Investors | |
| C CopySightCompany profile AI IP governance platform for copyright risk management in AI-generated content AI IP governance platform for copyright risk management in AI-generated content | $3M | Seed | Enterprise software | United States | Investors | |
| TB Developing nerve-targeted imaging technologies for surgery. | Undisclosed | Series A | Biotech | United States | Investors | |
| EA Develops enterprise AI agents for revenue-generating customer interactions. | $30M | Series A | Enterprise software | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Nous Research, Santé, Vitalize
125rounds3led - 2Andreessen Horowitz (a16z)
TypeSafe AI, Arena, Vesta
94rounds18led - 3General Catalyst
Minerva Humanoids, Melius
65rounds6led - 4Alumni Ventures
Savvy Wealth, Mona, American Supercritical
55rounds0led - 5Khosla Ventures
Arena, Vinci, Conway Research
54rounds5led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.